Literature DB >> 23499427

Detection and management of depression and/or anxiety for people with epilepsy in primary health care settings in Zambia.

Edward K Mbewe1, Leana R Uys, Gretchen L Birbeck.   

Abstract

PURPOSE: Among the 50 million people with epilepsy (PWE) worldwide ∼15 to 60% likely also suffer from depression and/or anxiety and 80% reside in low-income regions where human and technological resources for care are extremely limited.
METHODS: In Zambia, we carried out a retrospective chart review of 200 randomly selected files of PWE using a structured abstraction form to systematically collect socio-demographic data and clinical details on the detection and treatment of depression and/or anxiety.
RESULTS: Only 2 PWE (1%) had depression diagnosed and none were given a diagnosis of an anxiety disorder. Complaints suggestive of underlying depressive and/or anxiety disorders were documented in 120 (60%), but no diagnoses were made and no referrals, investigations or treatment were offered.
CONCLUSIONS: Further research is required to establish the prevalence of depression and anxiety among PWE in sub-Saharan Africa and efforts are needed to improve screening and treatment for common, treatable psychiatric comorbidities in PWE in resource limited settings.
Copyright © 2013 British Epilepsy Association. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23499427      PMCID: PMC3656350          DOI: 10.1016/j.seizure.2013.02.010

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

Review 1.  Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression.

Authors:  B P Hermann; M Seidenberg; B Bell
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

Review 2.  Epilepsy and common comorbidities: improving the outpatient epilepsy encounter.

Authors:  Frank G Gilliam; Anil Mendiratta; Alison M Pack; Carl W Bazil
Journal:  Epileptic Disord       Date:  2005-09       Impact factor: 1.819

3.  Depression and comorbidity in community-based patients with epilepsy or asthma.

Authors:  Alan Ettinger; Michael Reed; Joyce Cramer
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

4.  Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening.

Authors:  David E Friedman; Doris H Kung; Somchai Laowattana; Joseph S Kass; Richard A Hrachovy; Harvey S Levin
Journal:  Seizure       Date:  2009-05-05       Impact factor: 3.184

Review 5.  Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment.

Authors:  Andres M Kanner
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

6.  The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study.

Authors:  A Jacoby; G A Baker; N Steen; P Potts; D W Chadwick
Journal:  Epilepsia       Date:  1996-02       Impact factor: 5.864

  6 in total
  3 in total

Review 1.  Stigma in epilepsy.

Authors:  Kirsten M Fiest; Gretchen L Birbeck; Ann Jacoby; Nathalie Jette
Journal:  Curr Neurol Neurosci Rep       Date:  2014-05       Impact factor: 5.081

2.  The impact of a short depression and anxiety screening tool in epilepsy care in primary health care settings in Zambia.

Authors:  Edward K Mbewe; Leana R Uys; Gretchen L Birbeck
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

3.  Depression among epileptic patients and its association with drug therapy in sub-Saharan Africa: A systematic review and meta-analysis.

Authors:  Getenet Dessie; Henok Mulugeta; Cheru Tesema Leshargie; Fasil Wagnew; Sahai Burrowes
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.